Thrivent Financial for Lutherans Purchases 41,164 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR)

Thrivent Financial for Lutherans boosted its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR – Get Rating) by 54.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,231 shares of the medical instruments supplier’s stock after acquiring an additional 41,164 shares during the period. Thrivent Financial for Lutherans owned about 0.16% of OraSure Technologies worth $560,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in OSUR. FMR LLC boosted its stake in shares of OraSure Technologies by 249.6% during the second quarter. FMR LLC now owns 10,687 shares of the medical instruments supplier’s stock valued at $29,000 after purchasing an additional 7,630 shares in the last quarter. 1832 Asset Management L.P. bought a new stake in OraSure Technologies during the 1st quarter valued at $40,000. UBS Group AG increased its holdings in shares of OraSure Technologies by 82.3% in the 3rd quarter. UBS Group AG now owns 11,217 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 5,064 shares during the period. Jane Street Group LLC bought a new position in shares of OraSure Technologies in the 3rd quarter worth $49,000. Finally, ProShare Advisors LLC purchased a new stake in shares of OraSure Technologies during the 4th quarter worth $55,000. Hedge funds and other institutional investors own 85.62% of the company’s stock.

OraSure Technologies Trading Down 1.0 %

Shares of OSUR opened at $5.05 on Friday. The firm has a market cap of $369.97 million, a PE ratio of 12.95 and a beta of 0.08. OraSure Technologies, Inc. has a 12 month low of $2.62 and a 12 month high of $7.82. The stock has a fifty day moving average price of $6.38 and a 200-day moving average price of $5.67.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on OSUR shares. TheStreet upgraded OraSure Technologies from a “d+” rating to a “c” rating in a research note on Wednesday, May 10th. StockNews.com raised shares of OraSure Technologies from a “hold” rating to a “buy” rating in a research report on Friday, May 12th.

OraSure Technologies Profile

(Get Rating)

OraSure Technologies, Inc engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices.